CC-122
CA092-1000
Phase 1 small_molecule active
Quick answer
CC-122 for Non-Hodgkin Lymphoma is a Phase 1 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Non-Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active